Conmed (CNMD) Accumulated Expenses (2010 - 2026)

Conmed (CNMD) has 17 years of Accumulated Expenses data on file, last reported at $60.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 5.52% year-over-year to $60.9 million; the trailing twelve-month figure through Mar 2026 stood at $60.9 million (up 5.52% YoY), and the FY2025 full-year result was $82.1 million, up 25.66% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $60.9 million, down from $82.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $82.1 million in Q4 2025 and bottomed at $45.4 million in Q1 2022.
• The 5-year median for Accumulated Expenses is $57.7 million (2025), against an average of $59.8 million.
• The widest annual swing landed in 2022, when Accumulated Expenses retreated 9.51%; it then gained 28.02% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $54.7 million in 2022, then increased by 28.02% to $70.1 million in 2023, then fell by 6.71% to $65.4 million in 2024, then rose by 25.66% to $82.1 million in 2025, then slipped by 25.87% to $60.9 million in 2026.
• The last three Accumulated Expenses figures came in at $60.9 million (Q1 2026), $82.1 million (Q4 2025), and $76.1 million (Q3 2025), per Business Quant data.

Peer Comparison